Zusammenfassung
HIV 1, der Erreger der erworbenen Immunschwäche (Aids) zeichnet sich als Retrovirus durch besonders hohe Antigenvariationen und Heterogenität des Genoms aus. Dadurch kann das Immunsystem unterlaufen werden. Die Entwicklung einer effektiven Heterovakzine ist aus demselben Grund erschwert.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aboulker J-P, Swart AM (1993) Preliminary analysis of the Concordia trial. Lancet 341:889–890
Brüster HT, Kuntz BME, Scheja JW (1987) Die Behandlung von AIDS-und ARC-Patienten mit einer lymphozytaren Auto-Vaccine. Dtsch Ärztebl 13:818–824
Brüster HT, Kuntz BMF, Scheja JW (1988) Autovaccination plus heat-inactivated autologous plasma in AIDS-patients. Lancet 1:1284–1285 (letter)
Brüster HT (1990) HIV-autovaccine: a new method to treat AIDS and ARC patients. Transfusion Today: 8
Brüster HT, Scheja JW (1986) Quality control of blood and it’s compounds. Lab Med 8:471–481, 564–570
Scheja JW, Brüster HT (1984) A method for the determination of kallikrein system in plasma and blood products. Lab Med 7:276–281, 344–350
Scheja JW, Brüster HT (in press) Multivaried analysis in staging and monitoring HIV-infected individuals
Fischi MA et al. (1989) Prolonged Zidovudine therapy in patients with AIDS and advanced AIDS-related complex. JAMA 262/17:2405–2410
Velia et al. (1992) Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. JAMA 267:1232–1236
Janossy et al. (1991) Accessory cells in HIV and other retroviral infections. In: Racz P et al. Karger, Basel, pp 111–123
Fox CH, Couttler-Fox M (1992) The pathobiology of HIV infection. Immunology Today 13:353–356
Groux H, Torpier G, Monte D et al. (1992) [Beitrag in:] J Exp Med 175:331–340
Terai C, Kornbluth R, Pauza C, Richman D, Carson D (1991) [Beitrag in:] J Clin Invest 87:1710–1715
Laurent-Crawford AG, Krust B, Müller S et al. (1991) [Beitrag in:] Virology 185:829–839
Ameisen JC (1992) Programmed cell death and AIDS: from hypothesis to experiment. Immunology Today 13:388–391
Harms B, Kögler G, Wernet P, Brüster HT, Schneider EM (1991) Modulation of haematopoetic colony formation of stem cells in peripheral blood by anti-TGF-β in patients with severe immunosuppression. Klin Wochenschr 69:1139–1145
Habeshaw J, Hounsell H, Dalgleish A (1992) Does the HIV envelope induce a chronic graft-versus-host-like disease? Immunology Today 13:207–210
Kuntz BMF, Brüster HT (1989) Time-dependent variation of HLA-antigen-frequencies in HIV-1-infection (1983–1988). Tissue Antigens 34:164–169
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Brüster, H.T. et al. (1993). Langzeitstudie einer Therapie mittels lymphozytärer Autovakzine bei HIV-infizierten Patienten. In: Scharrer, I., Schramm, W. (eds) 23. Hämophilie-Symposion. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78359-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-78359-3_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56955-8
Online ISBN: 978-3-642-78359-3
eBook Packages: Springer Book Archive